Taken together, the above findings indicated that elevated levels of EDEM1 contribute to tumor progression and serve as an important indicator for poor prognosis in breast cancer patients, thus providing a potential therapeutic target for cancer prevention. The gene discussed is EDEM1; the disease is breast cancer.